Lithium technology has ushered in a new era of batteries with exceptionally high energy density for a reasonably low cost.

2seventy has been slimming down since the fall of 2023 until it was left with nothing else but the Abecma partnership with BMS. The Cambridge, Massachusetts-based biotech had divested its cell ...

BMS and 2seventy bio first teamed up in 2021. Credit: Moyo Studio via Getty Images. Bristol Myers Squibb (BMS) has agreed to acquire its longtime cell therapy partner 2seventy bio in a deal valued at ...

Bristol Myers Squibb is levering Fulcrum Therapeutics out of its life. MyoKardia, a biotech BMS bought in 2020, was working with Fulcrum to find cardiomyopathy targets but recently decided to end ...

Details on a BMS based on electrochemical impedance spectroscopy (EIS). BMS advances to keep pace with EV rising complexity. Building better battery models based on EIS characterization.